ANIP

ANI Pharmaceuticals, Inc

ANIP • NASDAQ

$72.60-$0.01 (0.01%)

Estimate

P/E

15.7

EPS

4.62

Beta

0.495

Growth

Revenue, YoY

25.87%

Net income, YoY

189.05%

FCF, YoY

-1.32%

Forecast

P/E (FWD)

7.1

EPS (FWD)

10.166

About the company

Ticker

ANIP

ISIN

US00182C1036

Country

United States of America

Sector (GICS)

Healthcare

ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally. The company provides injectables, softgel capsules, and Cortrophin gel, as well as ILUVIEN and YUTIQ products. It also manufactures oral solid dose products, semi-solids, liquids, topicals, controlled substances, and potent products. The company serves its products to national wholesalers, specialty pharmacies, retail pharmacy chains, distributors, mail order houses, group purchasing organizations, and hospitals and healthcare providers. ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Baudette, Minnesota.

Frequently asked questions

What sector does ANI Pharmaceuticals, Inc (ANIP) operate in?

ANI Pharmaceuticals, Inc belongs to the Healthcare sector and operates in the Drug Manufacturers - Specialty & Generic industry.

What is ANI Pharmaceuticals, Inc (ANIP) current stock price?

As of the latest data, ANI Pharmaceuticals, Inc stock price is $72.60, with a previous close of $72.61. ANI Pharmaceuticals, Inc lost -$0.01 in the last trading session, representing a -0.01% loss.

What is ANI Pharmaceuticals, Inc (ANIP) current market capitalization?

ANI Pharmaceuticals, Inc market cap is approximately 1.67 billion.

What is ANI Pharmaceuticals, Inc (ANIP) Earnings Per Share (EPS)?

The trailing EPS is $4.62, and the forward EPS is $10.17.

What is ANI Pharmaceuticals, Inc (ANIP) Price-to-Earnings (P/E) ratio?

ANI Pharmaceuticals, Inc current P/E ratio is 15.71, with a forward P/E of 7.14.

What is ANI Pharmaceuticals, Inc (ANIP) EBITDA?

ANI Pharmaceuticals, Inc EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 60.37 million.

Does ANI Pharmaceuticals, Inc (ANIP) pay dividends?

No. ANI Pharmaceuticals, Inc does not pay a dividend.

How did ANI Pharmaceuticals, Inc (ANIP) perform in its most recent earnings report?

In the last report (June 30, 2026), ANI Pharmaceuticals, Inc posted an EPS surprise of 8.98% and a revenue surprise of 2.27%.

When is ANI Pharmaceuticals, Inc (ANIP) next earnings report?

ANI Pharmaceuticals, Inc is expected to release its next earnings report on September 30, 2026.

What is ANI Pharmaceuticals, Inc (ANIP) beta (volatility) score?

ANI Pharmaceuticals, Inc has a beta of 0.495, indicating lower volatility than the overall market.